Alzheimer's Prevention Bulletin | Alzheimer's Prevention Registry

You are here

Alzheimer's Prevention Bulletin

Alzheimer’s Disease Awareness Month shines spotlight other dementias

Alzheimer’s disease makes up 60 to 80 percent of all dementias. But what else can cause memory and thinking problems? Learn more about other causes of dementia along with their varied symptoms.

Digital devices and artificial intelligence partner to measure early brain changes

Smartphones and smartwatches already measure our heart rate, sleep patterns and oxygen levels. These and other so-called digital biomarkers coupled with artificial intelligence could one day soon identify early memory and thinking changes to help us optimize our brain health.

Study explores whether computerized brain training can prevent dementia

A new, NIH-funded, multi-site study is exploring whether computerized brain training can prevent dementia. Preventing Alzheimer’s with Cognitive Training (PACT) will examine whether a specific type of computerized training can reduce the risk of dementia such as Alzheimer’s disease for adults over 65.  

New study uses tailored dosing approach that aims to help prevent Alzheimer’s

A new Alzheimer’s clinical trial is recruiting people as young as 55 to participate in a study of an anti-amyloid investigational therapy. The study is groundbreaking because the study medication doses are tailored based on each participant’s level of brain amyloid. Read more about how the AHEAD Study aims to get ahead of Alzheimer’s before symptoms appear. 

Improving your sleep and other lifestyle factors are keys to better brain health

Sleep is your body’s way of restoring vital organs including the brain. When sleep is elusive over long periods of time, research shows it can increase the risk of dementia and cognitive decline. You can reduce your risk by improving your sleep habits and addressing other lifestyle factors such as physical activity, diet, social engagement and smoking cessation. Read more about how to improve these aspects of your lifestyle.

First treatment in two decades approved for Alzheimer’s

The FDA approved the first new treatment for Alzheimer’s disease in almost two decades on June 7. Aducanumab is also the first approved drug to change the course of the disease by removing brain plaques, a signature of Alzheimer’s. But mixed results on its ability to slow the decline of memory and thinking skills caused some researchers to question the effectiveness of the novel treatment.

Discrimination and bias found in dementia care

The Alzheimer’s Association surveyed Black, Hispanic, Asian and Native Americans about their access to Alzheimer’s and dementia care. The results, which are reported in the 2021 Facts and Figures Report, show discrimination is a barrier to care for many minority groups. The report shares statistics from the survey and recommendations to combat discrimination in dementia care.

COVID-19 infection can harm the brain

Researchers are finding COVID-19 can significantly impact the brain. From neurological symptoms to mental well-being, the virus is taking a toll on the brain. In a new report the Global Council on Brain Health offers recommendations to safeguard your brain health during the pandemic.

Vaccines, gene therapy and other novel approaches to future Alzheimer’s treatments

Alzheimer’s researchers are seeking new ways to prevent and treat Alzheimer’s disease. Could novel treatments such as vaccines and gene therapy hold the key to a new type of treatment? Researchers are delving into that question.

Research shows intermittent fasting may prevent Alzheimer’s disease

Intermittent fasting is a popular option for weight loss. Scientists are now learning it may also be able to improve memory and thinking. Read more about potential option for delaying Alzheimer’s disease.